B2Y-28668-58326
3 vaccinations
9 coded responses
38 check-ins
9 free-text entries
9 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 666 / KS
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Registered in v-safe
-
2020-12-18
Dose 1 — Pfizer-BioNTech
- 2020-12-18
-
2020-12-19
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2020-12-20
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
-
2020-12-21
Survey response — days 1–6 daily, dose 1MedDRA: Rash, Self-medication — Feeling: Fair · Headache, Fatigue or tiredness · Be unable to workFree text: Rash on my legs I thought initially was dry skin. Went away with BenedrylMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-21
-
2020-12-22
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
-
2020-12-23
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
-
2020-12-24
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2020-12-25
- 2021-01-01
-
2021-01-08
Dose 2 — Pfizer-BioNTech
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-10
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-10
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-11
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-11
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-12
Survey response — days 1–6 daily, dose 2MedDRA: Medical counselling — Feeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: COVID hotline referred by supervisor, advised rest and fluids.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-12
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-13
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Fair · Fever · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-13
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-14
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-15
Survey response — day 7, dose 2MedDRA: Headache, Visual impairment — Feeling: Fair · Headache, Muscle or body achesFree text: Vision disturbance with headacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-22
- 2021-01-31
-
2021-02-05
Survey response — day 28, dose 2MedDRA: Rash — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Rash on legsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-05
Report sent to call center — day 28, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-12
Survey response — day 35, dose 2MedDRA: Office visit, Rash — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Continued rash on legs. · Healthcare visit (other): Referred to dermatologist due to continued/worsening rashMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-12
Report sent to call center — day 35, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-19
- 2021-02-19
-
2021-04-09
Survey response — 3 months, dose 2MedDRA: Dyspnoea, Poor quality sleep — Feeling: FairFree text: Intermittent shortness of breath and poor sleepMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-09
Survey response — 6 months, dose 2MedDRA: Cerebrovascular accident, Rash, Thrombosis — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Rash, blood clot in leg, stroke like symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-09
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-07-14
Call successfulParticipant prefers to complete VAERS report online
-
2021-10-04
Dose 3 — Pfizer-BioNTech
-
2021-10-05
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend schoolAdult check-in
-
2021-10-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-07
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-10-08
- 2021-10-09
-
2021-10-10
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-10-11
Health check-in — day 7, dose 3Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-10-18
- 2021-10-25
- 2021-11-01
- 2021-11-08
- 2021-11-15
-
2022-01-05
Survey response — 3 months, dose 3MedDRA: Dyspnoea, Visual impairment — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Shortness of breath at times. Vision changes.MedDRA releases: 2024-11 · check-in free text available
- 2022-04-05
- 2022-10-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-10-04 | Pfizer-BioNTech | No |
Call center
9 call center cases
9 successful
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Rash on my legs I thought initially was dry skin. Went away with Benedryl
Release 1 — days 1–6 daily, dose 2
Healthcare visit (other): COVID hotline referred by supervisor, advised rest and fluids.
Systemic reaction (other): Dizziness
Release 2 — day 7, dose 2
Systemic reaction (other): Vision disturbance with headache
Release 3 — day 28, dose 2
Symptoms: Rash on legs
Release 4 — day 35, dose 2
Symptoms: Continued rash on legs.
Healthcare visit (other): Referred to dermatologist due to continued/worsening rash
Release 7 — 3 months, dose 2
Symptoms: Intermittent shortness of breath and poor sleep
Release 9 — 6 months, dose 2
Symptoms: Rash, blood clot in leg, stroke like symptoms
Release 10 — 3 months, dose 3
Symptoms: Shortness of breath at times. Vision changes.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | ✓ | ✓ | ✓ |
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Cerebrovascular accident | ✓ | ✓ | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Poor quality sleep | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Thrombosis | ✓ | ✓ | ✓ |
| SD | Visual impairment | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Rash | ✓ | ✓ | ✓ |
| SRO | Self-medication | ✓ | ✓ | ✓ |
| SRO | Visual impairment | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release